RCEL
RCEL
NASDAQ · Biotechnology

Avita Medical Inc

$3.90
-0.03 (-0.76%)
As of Feb 8, 2:10 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 28.35M 25.19M 23.71M
Net Income -3,552,057 -2,467,246 -2,847,172
EPS
Profit Margin -12.5% -9.8% -12.0%
Rev Growth +16.8% +20.8% +14.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 28.88M 29.07M 27.04M
Total Equity 72.52M 72.39M 66.00M
D/E Ratio 0.40 0.40 0.41
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -4,683,797 -4,050,890 -3,804,791
Free Cash Flow -2,316,217 -1,532,934 -2,480,233